EUVIMEDOpdag EUVIMED
Multizentrische StudieBeobachtungsstudieVergleichsstudieOpen access

Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study

Diego Santos-García iD, Ángela Solleiro, Guillermo González-Ortega iD, Pablo Mir iD, Nuria López-Ariztegui iD, Rocío García Ramos, Inés Legarda, Anna Planas-Ballvé, Deborah Alonso-Modino, Pilar Sánchez-Alonso, Iria Cabo, Marta Blázquez-Estrada and 2 more

Movement Disorders Clinical Practice · 2026-01 · 13 (1) · 154-172

DOI: 10.1002/mdc3.70239 ↗

At a glance

Multizentrische Studie in Movement Disorders Clinical Practice, published online on 2025-07-24. Written by Diego Santos-García and 13 co-authors. Institution: CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. Major MEDLINE topics: Parkinson Disease, Antiparkinson Agents, Deep Brain Stimulation. Cited 8 times so far (Crossref); 60 references. The full text is freely available in PubMed Central. Funded by: Fundación Novoa Santos.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and objective New device‐aided therapies (DATs) have emerged to treat people with Parkinson's disease (PwP). Our aim was to know which DATs were indicated by the neurologist and to compare the characteristics of the patients treated under real clinical practice in Spain in the year 2024. Patients and methods Data collected in the DATs‐PD GETM Spanish Registry were used (REDCap). This is a descriptive, observational, prospective, multicenter, clinical registry with progressive inclusion of PwP treated with a DAT in daily clinical practice conditions in more than 40 centers from Spain for 10 years. For this proposal, only data from visit V1 (indication of DAT) were analyzed, but no follow‐up data. All patients with information on DAT received until 31/DEC/2024 were included.

Results

A total of 313 PD patients (66.7 ± 9.6 years old at V2 ; 61.7% males) were treated with a DAT . The most frequent DAT was subcutaneous foslevodopa/foscarbidopa ( fLD / fCD ) (47%) followed by deep brain stimulation ( DBS ) (20.1%) and continuous subcutaneous apomorphine infusion ( CSAI ) (19.8%). Up to 23.6% had received at least one previous DAT and 47% an on‐demand therapy. Differences in age, time with fluctuations and other aspects (motor status, quality of life or activities of daily living among others) were observed between different DAT groups. Specifically, patients treated with DBS were younger and had less advanced disease, whereas those who received LECIG were the most affected.

Conclusion

Subcutaneous therapies and DBS were the most frequent DATs (86.9%) implemented in Spain in 2024. Profile differences were detected between DAT types.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseAntiparkinson AgentsDeep Brain StimulationHumansMaleSpainFemaleAgedMiddle AgedProspective StudiesRegistries

Author keywords

Parkinson's diseasedeep brain stimulationdevice‐aided therapiesinfusionregistrysubcutaneous

Substances

Antiparkinson Agents

Authors and institutions

  • CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Grupo de Investigación en Enfermedad de Parkinson y otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), A Coruña, Spain.
  • Hospital San Rafael, A Coruña.
  • Fundación Degen, A Coruña, Spain.
  • Hospital Universitario de Móstoles, Madrid, Spain.
  • Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.

ORCID profiles: Diego Santos-García, Guillermo González-Ortega, Pablo Mir, Nuria López-Ariztegui

Funding

  • Fundación Novoa Santos

Cite

APA

Santos-García, D., Solleiro, Á., González-Ortega, G., Mir, P., López-Ariztegui, N., García Ramos, R., Legarda, I., Planas-Ballvé, A., Alonso-Modino, D., Sánchez-Alonso, P., Cabo, I., Blázquez-Estrada, M., Sánchez-Ferro, Á., & DATs‐PD GETM Spanish Registry Group (2026). Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study. Movement Disorders Clinical Practice, 13(1), 154-172. https://doi.org/10.1002/mdc3.70239

Vancouver

Santos-García D, Solleiro Á, González-Ortega G, Mir P, López-Ariztegui N, García Ramos R, et al. Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study. Movement Disorders Clinical Practice. 2026;13(1):154-172. doi:10.1002/mdc3.70239

BibTeX
@article{SantosGarca2026,
  author = {Santos-García, Diego and Solleiro, Ángela and González-Ortega, Guillermo and Mir, Pablo and López-Ariztegui, Nuria and García Ramos, Rocío and Legarda, Inés and Planas-Ballvé, Anna and Alonso-Modino, Deborah and Sánchez-Alonso, Pilar and Cabo, Iria and Blázquez-Estrada, Marta and Sánchez-Ferro, Álvaro and DATs‐PD GETM Spanish Registry Group, DATs‐PD GETM Spanish Registry Group},
  title = {Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {154--172},
  doi = {10.1002/mdc3.70239}
}
Start for free →